Tsujino S, Tonin P, Shanske S, Nohria V, Boustany R M, Lewis D, Chen Y T, DiMauro S
H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Disease, Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY 10032.
Ann Neurol. 1994 Mar;35(3):349-53. doi: 10.1002/ana.410350316.
We report on a 12-year-old boy with the myopathic form of phosphoglycerate kinase (PGK) deficiency, and unique kinetic and physical characteristics of the mutant enzyme (PGK North Carolina). A G-to-T substitution at the 5' end of intron 4 was identified in the PGK gene of this patient. The mutation destroys the consensus sequence GT at the 5' splice junction of the intron. Activation of a cryptic splice site within intron 4 causes the insertion into the transcript of a 30-bp fragment at the 5' end of intron 4. This insertion results in ten additional amino acids within the "nose" of the PGK molecule, but does not generate a frameshift or a premature stop codon.
我们报告了一名患有肌病型磷酸甘油酸激酶(PGK)缺乏症的12岁男孩,以及突变酶(PGK北卡罗来纳型)独特的动力学和物理特性。在该患者的PGK基因中,在内含子4的5'端鉴定出一个G到T的替换。该突变破坏了内含子5'剪接位点处的共有序列GT。内含子4内一个隐蔽剪接位点的激活导致在转录本中内含子4的5'端插入一个30 bp的片段。这种插入在PGK分子的“头部”产生了另外十个氨基酸,但没有产生移码或提前终止密码子。